PrEPX South Australia
Alfred Health’s highly successful PrEPX study for those at risk for HIV infection will be expanded into South Australia thanks to a new partnership with South Australian Health & Medical Research Institute (SAHMRI) and SA Health.
PrEPX-SA is now recruiting people to take part in the study.
Victorian PrEPX information is available here.
What is PrEPX-SA?
PrEPX-SA will monitor how providing large-scale access to Pre-Exposure Prophylaxis (PrEP) medication impacts the rate of new infections across the state. There will be 500 places available in the study.
This study is funded by the Government of South Australia. The South Australian Health & Medical Research Institute (SAHMRI) will provide the leadership and coordination of the project.
PrEPX-SA opened on the 15th May 2017. To access the study you will need to join the PrEPX-SA waiting list.
How will the study work?
We will be taking people off the waiting list every few months until the study is fully enrolled. You will receive an email when we are able to offer you the opportunity to enrol at one of the PrEPX-SA clinics.
The following clinics will be a part of PrEPX-SA:
- Clinic 275
- O’Brien St General Practice
- SHine-SA Hyde St
- Riverside Family Medical Practice
What costs are involved?
A PBS co-payment for the study medication will be in place for PrEPX-SA study participants.
We plan that the medication will be able to be collected from The Centre Pharmacy located in Central Market Arcade.
- Concession: $6.30
- Non-concession: $38.80
In the study this co-payment cost will cover three months’ supply.
Criteria for the study
All people, regardless of sexual orientation or gender are eligible for the study. PrEPX-SA will enroll people whose sexual or injecting drug use activities means there is a high risk of acquiring HIV infection. This level of risk is defined through discussions with doctors, nurses or peer workers.
To be eligible for the study you will need to:
- have a medicare card
- be over 18 years of age
- have no confounding health issues for the study
More detailed criteria will be in the study consent form which will be available closer to us opening in South Australia.
Information about PrEP
HIV Pre-Exposure Prophylaxis (PrEP) is a once-a-day medication for HIV negative people, to reduce their risk of acquiring HIV. It is recommended that PrEP is taken every day to effectively reduce the risk.